跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Clirnaze - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Clirnaze
Approved
STANDARD
Clirnaze
Lifesquare Laboratories Inc.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
f96ba5efe77456bf
Company
Lifesquare Laboratories Inc.
Type
Standard
Approval Details
Approval Id
f96ba5efe77456bf
Drug Approval Philippines Name
Clirnaze
Product Name
Clirnaze
Registration Number
DRP-8484-02
Brand Name
Clirnaze
Generic Name
Sodium Chloride
Dosage Form
Nasal Spray
Dosage Strength
6.5mg per mL
Manufacturer
Lifesquare Laboratories Inc.
Distributor
Novomed Inc.
Issuance Date
28 April 2024
Expiry Date
17 October 2029
Pharmacologic Category
Nasal Decongestant
Classification
Over-the-Counter (OTC) Drug
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
f96ba5efe77456bf
Type
Standard
Back to Philippines FDA Approvals